Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Biotek-snakken
  4. Biotek-snakken — December 2024

Biotek-snakken — December 2024

Planlagt Fastgjort Låst Flyttet Biotek-snakken
37 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • F Offline
    F Offline
    Fandel
    wrote on sidst redigeret af
    #18

    Godmorgen...

    1 Reply Last reply
    0
    • L Offline
      L Offline
      LP90
      wrote on sidst redigeret af
      #19

      Godmorgen 🙂

      1 Reply Last reply
      0
      • exitnuE Offline
        exitnuE Offline
        exitnu
        wrote on sidst redigeret af
        #20

        Bud på: Abliva - oppe med +200% i dag ...

        Statement by the Board of Directors of Abliva regarding the public cash offer from Pharming

        Link Preview Image
        Abliva – Delivering mitochondrial health

        Abliva develops medicines for the treatment of primary mitochondrial diseases.

        favicon

        (abliva.com)

        Research & Development

        Link Preview Image
        Research & Development – Abliva

        Abliva’s in-house R&D capabilities have been instrumental in creating and delivering a portfolio that includes several projects with mechani ...

        favicon

        (abliva.com)

        1 Reply Last reply
        0
        • exitnuE Offline
          exitnuE Offline
          exitnu
          wrote on sidst redigeret af
          #21

          Medivir obtains IND approval for fostrox - the first oral, liver-targeted treatment for advanced liver cancer

          Link Preview Image
          Press release

          favicon

          Medivir (www.medivir.com)

          Jeg har taget en pæn position i svenske Medivir i dag med baggrund i deres pressemeddelelse. Skrevet efter luk ...

          1 Reply Last reply
          0
          • exitnuE Offline
            exitnuE Offline
            exitnu
            wrote on sidst redigeret af
            #22

            Medivirs vd: “IND-godkännandet är en mycket viktig milstolpe”

            Attention Required! | Cloudflare

            favicon

            (www.biostock.se)

            Medivir: IND Approval for Phase IIb

            Just a moment...

            favicon

            (www.redeye.se)

            1 Reply Last reply
            0
            • exitnuE Offline
              exitnuE Offline
              exitnu
              wrote on sidst redigeret af
              #23

              Nordnet; Anbefalinger fra analytikere: 2 køb. Kursmål 10,68 til 54,00 SEK (Udfaldsrum - 1 års forecast).

              1 Reply Last reply
              0
              • F Offline
                F Offline
                Fandel
                wrote on sidst redigeret af
                #24

                Godmorgen...

                1 Reply Last reply
                0
                • L Offline
                  L Offline
                  LP90
                  wrote on sidst redigeret af
                  #25

                  Godmorgen 🙂

                  1 Reply Last reply
                  0
                  • F Offline
                    F Offline
                    Fandel
                    wrote on sidst redigeret af
                    #26

                    Godmorgen...

                    1 Reply Last reply
                    0
                    • H Offline
                      H Offline
                      Hansen
                      wrote on sidst redigeret af
                      #27

                      Hvad sker her Cognition Therapeutics+ oppe med nøsten 200%

                      1 Reply Last reply
                      0
                      • H Offline
                        H Offline
                        Hansen
                        wrote on sidst redigeret af
                        #28

                        Ok, det var det her https://ir.cogrx.com/press_releases/cognition-therapeutics-announces-positive-results-in-phase-2-study-of-ct1812-in-dementia-with-lewy-bodies/

                        1 Reply Last reply
                        0
                        • exitnuE Offline
                          exitnuE Offline
                          exitnu
                          wrote on sidst redigeret af
                          #29

                          Medivir to present final safety and efficacy data for fostrox + Lenvima in advanced liver cancer at EASL Liver Cancer Summit

                          Link Preview Image
                          Press release

                          favicon

                          Medivir (www.medivir.com)

                          1 Reply Last reply
                          0
                          • F Offline
                            F Offline
                            Fandel
                            wrote on sidst redigeret af
                            #30

                            Godmorgen...

                            1 Reply Last reply
                            0
                            • L Offline
                              L Offline
                              LP90
                              wrote on sidst redigeret af
                              #31

                              Godmorgen 🙂

                              1 Reply Last reply
                              0
                              • exitnuE Offline
                                exitnuE Offline
                                exitnu
                                wrote on sidst redigeret af
                                #32

                                IBT fortsätter utvecklingen av läkemedelskandidaten IBP-9414

                                1 Reply Last reply
                                0
                                • exitnuE Offline
                                  exitnuE Offline
                                  exitnu
                                  wrote on sidst redigeret af
                                  #33

                                  IBT erhöll resultat i augusti från den största genomförda randomiserade kliniska studien någonsin på för tidigt födda barn. Under hösten har IBT fortsatt att granska fas 3-resultaten. Delar av resultaten har tidigare kommunicerats samt presenterats av studiens "principal investigator" vid Hot Topics-konferensen i Washington DC i början av december.

                                  1 Reply Last reply
                                  0
                                  • exitnuE Offline
                                    exitnuE Offline
                                    exitnu
                                    wrote on sidst redigeret af
                                    #34

                                    "Det är tillfredsställande att vi efter höstens granskningar fortsatt siktar på att lansera vårt läkemedel IBP-9414 så snart som möjligt. Det är goda nyheter för alla barn som är i behov av vår behandling för att förbättra deras överlevnadsmöjligheter", säger Staffan Strömberg, vd IBT.

                                    1 Reply Last reply
                                    0
                                    • exitnuE Offline
                                      exitnuE Offline
                                      exitnu
                                      wrote on sidst redigeret af
                                      #35

                                      IBT Continues Development of Drug Candidate IBP-9414

                                      Link Preview Image
                                      IBT | IBT Continues Development of Drug Candidate IBP-9414

                                      favicon

                                      (ibtherapeutics.com)

                                      1 Reply Last reply
                                      0
                                      • exitnuE Offline
                                        exitnuE Offline
                                        exitnu
                                        wrote on sidst redigeret af
                                        #36

                                        Tak til CEO Staffan Strömberg og resten af det fantastisk team i Infant Bacterial Therapeutics 🙂

                                        1 Reply Last reply
                                        0
                                        • exitnuE Offline
                                          exitnuE Offline
                                          exitnu
                                          wrote on sidst redigeret af
                                          #37

                                          .. fantastiske team .. mangler et e eller r i ny og næ .. beklager 🙂

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper